# A Randomized Trial of Itraconazole in Acute Stages of Allergic Bronchopulmonary Aspergillosis

> **NCT02440009** · PHASE2,PHASE3 · COMPLETED · sponsor: **Post Graduate Institute of Medical Education and Research, Chandigarh** · enrollment: 191 (actual)

## Conditions studied

- Allergic Bronchopulmonary Aspergillosis

## Interventions

- **DRUG:** Itraconazole
- **DRUG:** Glucocorticoids

## Key facts

- **NCT ID:** NCT02440009
- **Lead sponsor:** Post Graduate Institute of Medical Education and Research, Chandigarh
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-05
- **Primary completion:** 2017-07
- **Final completion:** 2017-07-31
- **Target enrollment:** 191 (ACTUAL)
- **Last updated:** 2022-10-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02440009

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02440009, "A Randomized Trial of Itraconazole in Acute Stages of Allergic Bronchopulmonary Aspergillosis". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT02440009. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*